ENO1 and breast carcinoma: For instance, extracellular Eno1 recombinant proteins are reported to suppress the metabolic activities of breast cancer cells and act as cytotoxic agents by downregulating Snail, TGFβ, and MMP9 [39], and its antitumor action was shown to be mediated by the Eno1-CD44 regulatory axis.